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Objective To investigate the situation among Chinese patients with regard to infection with multiple strains of
Helicobacter pylori.
Methods Biopsy specimens for culture of H. pylori were obtained from gastric antrum, body and fundus
of 20 patients during endoscopic investigation of upper gastrointestinal symptoms. H. pylori was identified by
culture from one site in 16 and two or more sites in 10 of the 16 patients. Five isolated colonies of six strains of
H. pylori from gastric antrum were subcultured and used for further analysis. Antibiotic susceptibility to
metronidazole and clarithromycin was determined by disk diffusion test. Protein profiles of isolates were
compared by sodium dodecylsulfate–polyacrylamide gel electrophoresis (SDS-PAGE). DNA diversity of the
isolates was determined by arbitrarily primed polymerase chain reaction (AP-PCR) fingerprinting.
Results Of the 10 patients with multiple isolates, 70% (7/10) exhibited variation in susceptibility to
metronidazole and 20% (2/10) to clarithromycin between different sites. In 83% of (5/6) single colonies, no
variability was seen in metronidazole and clarithromycin susceptibility; they were either susceptible or
resistant. Protein profiles of all isolates by SDS-PAGE were similar. Isolates from different patients produced
clearly different AP-PCR fingerprints. In 50% of H. pylori strains isolated from different sites of the stomach,
genetic diversity was demonstrated by different AP-PCR fingerprints. In 67% (4/6) strains, five single-
colony fingerprints were similar.
Conclusions Genetic variability has been found in H. pylori strains. Individual patients are infected with
a single predominant genotype at a single site but can be colonized by multiple strains, and they may show
different antibiotic susceptibilities. Individual colonies of the H. pylori population from a single site may not
always yield identical DNA fingerprints and antibiotic sensitivities.
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INTRODUCTION
Helicobacter pylori is a microaerobic Gram-negative spiral to
curved bacterium isolated from the stomach in humans. It is
unambiguously implicated in the pathogenesis of active chronic
gastritis, peptic ulcer disease and gastric cancer [1,2]. It is usually
detected in the antrum, but has also been found in the body and
fundus of the stomach. H. pylori infection occurs at an early age,
and over three-quarters of the developing world population has
been found to be infected [3]. A high level of genomic
heterogeneity has been shown among H. pylori isolates from
patients in different Western countries [4]. The various typing
techniques for H. pylori include restriction of genomic DNA
[4], ribotyping [5], protein profiling [6], arbitrarily primed
polymerase chain reaction (AP-PCR) fingerprinting [7], poly-
merase chain reaction (PCR) restriction fragment length poly-
morphism (RFLP) analysis [8], and repetitive extragenic
palindromic DNA sequence-based PCR (REP-PCR) analysis
[9]. In this paper, we report a study that examined H. pylori
isolates from different anatomic sites of the stomach using
sodium dodecylsulfate polyacrylamide gel electrophoresis
(SDS-PAGE) and AP-PCR analysis in a group of Chinese
patients with peptic ulcer disease. The aim was to find whether
different H. pylori strains are found at different sites within an
individual patient. We also examined five single colonies grown
from each of six positive biopsy specimens obtained from
different patients, in order to determine whether more than
one strain of H. pylori was present in any single biopsy specimen
and whether they also varied in their antibiotic susceptibility.
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Twenty patients presenting to the gastroenterology department
of Xiangya Hospital for routine endoscopic assessment of their
upper gastrointestinal tract symptoms from October 1998 to
June 1999 were investigated. Potential carriers of H. pylori were
identified by history, and none had taken antibiotics, proton
pump inhibitors or bismuth within the previous 3 months.
From these patients, biopsy specimens for urease test and culture
of H. pylori were obtained from three different sites, i.e. gastric
antrum, body and fundus, in 10 patients, and from only one site
in six patients. In these six patients, we did not take samples from
fundus and body for technical reasons. H. pylori was identified
by culture in at least one biopsy specimen from 16 of the 20
patients, and 30 isolates were obtained from 72 biopsy samples.
It was cultured from only one site, i.e. antrum, in six patients,
from two sites in six patients (antrum and body in two, antrum
and fundus in three, and body and fundus in one), and from
three sites (gastric antrum, body and fundus) in four patients.
Patients with negative H. pylori culture were also negative by
urease test. At endoscopy, seven of the 16 patients had superficial
gastritis, five patients had gastric ulcer, and four patients had
duodenal ulcer. We selected 10 patients with positive H. pylori
culture from more than one site for this study (Table 1). The
male/female ratio of this group of patients was 11 : 5, and mean
age was 35.2 years.
Antibiotic susceptibility testing
Techniques validated in previous studies were used for suscept-
ibility testing of isolates of H. pylori to clarithromycin and
metronidazole [10,11].
SDS-PAGE for protein profile
Bacterial cells were collected from culture plates and washed
with phosphate-buffered saline (PBS). The pellet was resus-
pended in 25 mL of PBS and in 15 mL of SDS-PAGE sample













































































































11 Male 40 Gastric ulcer 1 Antrum S S C
12 Female 45 Gastric ulcer 1 Antrum R R C
13 Male 35 Superficial gastritis 1 Antrum R S C
14 Male 26 Duodenal ulcer 1 Antrum S R C
15 Female 38 Superficial gastritis 1 Antrum R S D
16 Male 40 Duodenal ulcer 1 Antrum R R D
S, susceptible; R, resistant; D, different; C, common.
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buffer containing 100 mM trichloroacetic–hydrochloric acid
(Tris-Cl, pH 6.8), 200 mM dithiothreitol, 4% SDS (electro-
phoresis grade), 0.2% bromophenol blue, and 20% glycerol,
and the mixture was boiled for 3 min. Later, the samples were
vortexed for 1 min and then stored at 208C prior to electro-
phoresis. Extracted proteins were electrophoresed in a 5% stack-
ing and 12.5% acrylamide resolving gel [12] and visualized
with 0.1% Coomassie brilliant blue R250. The SDS-PAGE
procedure was performed at room temperature for 8 h at
50 V.
Extraction of genomic DNA
The bacterial cells on chocolate agar plate were washed twice
with PBS, and then centrifuged at 3000g for 20 min. H. pylori
DNA was extracted using a phenol/chloroform method similar
to that previously described by Majewski and Goodwin [4].
AP-PCR fingerprinting
PCR was carried out in a final volume of 50 mL containing
20 ng of H. pylori genomic DNA, 3 mM magnesium chloride,
100 pmol of each primer, 2.0 units of Taq DNA polymerase, and
4 mM each of dCTP, dGTP, dTTP and dATP in double-
distilled water. The mixture was overlaid with mineral oil. All
the reagents were bought from the Sino-American Biotechno-
logyCompany (SABC), Shanghai,China. Theprimers usedwere
a combination of two 10-nucleotide primers, obtained from
Genosys Europe, Cambridge, UK. These are random primers
whicharenot taken fromanypart of theH.pylorigenome.Forour
study,weusedprimer1281 (AACGCGCAAC) and primer 1254
(CCGCAGCCAA), which have been successfully used before
[8,13]. A thermal cycler (Perkin-Elmer 480, Cetus, USA) was
used for amplification. The cycling program was as follows: four
cycles (948C, 5 min; 368C, 5 min; 728C, 5 min), 30 cycles
(948C, 1 min; 368C, 1 min; 728C, 2 min) and then 728C for
10 min. After PCR, 15-mL aliquots of products were electro-
phoresed in 2% agarose gels containing 0.5 mg/L ethidium
bromide in the gel and 1Tris-acetate running buffer. The
PCR product of standard strain ATCC 49503 was used as a
positive control and double-distilled water as a negative control
for electrophoresis. The PCR marker (SABC) was used as a size
marker (M) in all gels.
RESULTS
Susceptibility testing
See Tables 2 and 3.
SDS-PAGE for protein profile
The protein profiles of all H. pylori strains and their single
colonies were examined by SDS-PAGE, and clear protein
patterns were seen in each of the 30 strains. In our study,
protein profiles differed from other studies in terms of total
number of bands [13,14], but gave similar results in terms
of major bands and a similar profile from one strain to another.
SDS-PAGE protein profiles had less discriminatory power
when compared with AP-PCR. This is in keeping with
our results presented before (accepted for publication by
APMIS).
Table2 Results of susceptibility testing of H. pylori and AP-PCR fingerprinting for patients with multiple isolates cultured from the gastric antrum and
body/fundus
Metronidazole phenotype Clarithromycin phenotype AP-PCR fingerprinting
Patterns of susceptibility Antrum Body Fundus Antrum Body Fundus Antrum Body Fundus
Patients with three isolates
1 S R S S S S C D C
2 R R S S S S C C C
3 R R S R R S C C C
4 S R S S R S C C C
Patients with two site isolates
1 R ND R S ND S D ND D
2 S ND R S ND S D ND D
3 S ND R S ND S D ND D
4 S R ND S S ND D D ND
5 S S ND S S ND C C ND
6 ND S S ND S S ND C C
S, susceptible; R, resistant; C, common; D, different; ND, not determined.
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AP-PCR fingerprinting
AP-PCRfingerprintingwithacombinationoftwo10-nucleotide
primers yielded 5–8 bands on the agarose gels. DNA types were
defined on the basis of clearly distinct AP-PCR fingerprints
with multiple band differences, i.e. more than one band, and
subtypes were defined when only one band was different.
Fifteen different AP-PCR fingerprints were identified among
the set of isolates from 10 individual patients. These included
five patients each with two AP-PCR fingerprints among their
isolates (Figure 1). All isolates within a patient set were far more
similar to each other in visual comparisons than to any other
isolate from any other patient (Figure 1). In 50% of patients, a
single predominant strain was found in different sites with no
apparent difference in the AP-PCR fingerprints (Figure 1).
Single colonies
AP-PCR fingerprints were generated for a total of 30 colonies
of H. pylori obtained from six H. pylori strains. DNA fingerprints
from five colonies of an H. pylori strain demonstrated identical
DNA band profiles in four of six patients. In these four patients,
five single-colony fingerprints were highly similar. In two of six
strains, CC981125 and CC981212, two single-colony band
patterns were not similar to each other or to the other three
single colonies (Figure 2a, lanes 3, 7, 8 and 12), whereas all five
single-colony band patterns of strains CC990122, CC981204,
CC981010 and CC981122 were similar (Figure 2a, lanes
13–17, and Figure 2b).
Table 3 Results of susceptibility testing ofH. pylori and AP-PCR fingerprinting for patients with single isolates from antrum (examination of single colonies)
Metronidazole phenotype Clarithromycin phenotype AP-PCR fingerprinting
S R Resistance rate (%) S R Resistance rate (%) D C
1 5 ^ ^ 5 ^ ^ ^ 5
2 ^ 5 100 ^ 5 100 ^ 5
3 ^ 5 100 5 ^ ^ ^ 5
4 5 ^ ^ ^ 5 100 ^ 5
5 2 3 60 5 ^ ^ 2 3
6 ^ 5 100 2 3 60 2 3
S, susceptibility; R, resistant; C, common; D, different; ND, not determined.
Figure 1(a)/(b) PCR-RAPD fingerprinting 1-10 of clinical isolates CC
981108, CC981110, CC981112, CC981117, CC981118, CC981121, CC981119,
CC981120, CC981127, CC981103, CC981104, CC981105, CC981114,
CC981115, CC981123, CC981124, CC981126, CC981128, CC981107,
CC981109, CC981214, CC981216, CC981218, CC981220 of H. pylori. PCR-
RAPD fingerprinting of clinical isolates of H. pylori. The profiles show that
different strains were cultured from multiple sites. (A) Antrum, (B) Body,
(F) Fundus, (M) PCR maker, (Nc) negative control, (Pc) positive control
with PCR product of standard strain ATCC 49503.
Figure 2(a)/(b) PCR-RAPD fingerprintingof five single colonies of six clin-
ical isolates CC981212, CC981125, CC990122, CC981204, CC981010,
CC981122 of H. pylori. M, PCR marker; Nc, negative control; Pc, positive
controlwith PCRproduct of standard strainsNCTC11637 andATCC49503.
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DISCUSSION
Evidence suggests that, typically, only one strain of H. pylori is
responsible for H. pylori infection in individual patients [15,16].
There are studies which show that almost all strains of H. pylori
isolated from different sites in the stomach of individual patients
show the same DNA profiles [15]. Strains of H. pylori isolated
from an individual patient at different times, and stored and
cultured several times, always had the same DNA type [16]. In
contrast, Beji et al [17] described patients infected with different
strains of H. pylori isolates. In this study, one biopsy specimen
was taken from three different sites of the stomach in an individual
patient during the same visit. We found pronounced genetic
diversity between H. pylori strains from different patients and
isolates from different parts of the same patients. Importantly,
we have established that our patients may be colonized with more
thanonestrainofH.pyloriatone time.Themajorityofpatientshad
a predominant infecting strain distributed on the antrum of the
stomach, but the fundus or body strain was different.
This study showed that two different H. pylori strains can
coexist in an infected individual and may not be uniformly
distributed among biopsy sites. These diverse strains may not
exhibit the same antibiotic susceptibility. The drawback of
limiting analysis to a single-site isolate and its single colonies
is that there may be a different strain with varying antibiotic
susceptibility colonizing the other sites. Strains isolated from
antrum are likely to be antibiotic sensitive, but the strains from
body and fundus may be resistant (Tables 1–3). However, this
needs to be further evaluated in a larger sample size, and this
is ongoing at the moment in our hospital. Although H. pylori
DNA fingerprints are highly stable in the laboratory, it is
possible that H. pylori exhibits genetic instability in vivo, and
years of unremitting infection may result in the survival of
usually one dominant or successful strain. The presence of a
particular strain may inhibit or prevent colonization by different
strains on sequential exposure. This might be explained by some
studies showing that bacterial strains differ in their specificity
of adherence to host receptors [18]. Thus isolates may be better
suited for colonization and growth in some human hosts than
in others. Hua et al [19] showed that a single strain of H. pylori
was harbored by the gastric antrum, and in vitro interaction of
two different strains of H. pylori resulted in the predominance
of a single strain. On commencement of antibiotics, the dom-
inant H. pylori strain, which is sensitive to the antibiotics, is
eradicated and the underlying inhibited strain grows to become
dominant. This results in a relapse of H. pylori infection.
Marshall et al [20] showed that DNA fingerprints of individual
colonies obtained from the same antral biopsy specimen were in
all cases indistinguishable. In our study, examination of the five
single colonies demonstrated two patients each with two colo-
nies, respectively, having distinctly different AP-PCR finger-
print and antibiotic sensitivity, suggesting different strains of
H. pylori. It is possible that changes/mutations such as genomic
rearrangement and natural transformation may lead to strain
development during the lifelong infection of a patient [21].
However, it may also suggest infection with multiple strains of
H. pylori during childhood or later in life.
The distribution of metronidazole-sensitive and -resistant
isolates between antrum and other sites suggests an increased
possibility of failure of therapies that include metronidazole.
The antral biopsy isolates which were metronidazole sensitive in
only 53% of the cases stress the importance of taking three site
biopsies for determining drug sensitivities of isolates in patients
with recurrent peptic ulcer disease. The existence of metroni-
dazole-resistant H. pylori isolates also suggests previous unsuc-
cessful treatment of H. pylori infection. The implication of this
study for Chinese clinicians is that metronidazole resistance is
quite common and multiple diverse H. pylori strains may be
responsible for an H. pylori infection. When a first-line treat-
ment containing nitroimidazole or a macrolide has failed, the
antimicrobial susceptibility should be ascertained. In cases of
dual resistance, alternative treatment regimens should be used.
CONCLUSION
We can conclude from this study that there is genomic diversity
among H. pylori strains isolated from different sites of the
stomach in Chinese patients. One individual patient can be
colonized by multiple strains. In an individual patient, H. pylori
strains isolated from various sites may have different antibiotic
susceptibilities.
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